Delayed diagnosis after atypical glandular cells on cervical cytology

Journal of Lower Genital Tract Disease

Volumn 13, Issue 4, 2009, Pages 237-243

  Schnatz, Peter F ^a,b,c   Surette, Ann Marie ^a,b   O'Sullivan, David M ^a  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c READING HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Atypical glandular cells (AGCs); Cervical disease; Colposcopy; Delayed diagnosis; Dysplasia malignancy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; COLORECTAL CANCER; CONTROLLED STUDY; DELAYED DIAGNOSIS; ENDOCERVICAL GLANDULAR DYSPLASIA; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; UTERUS CANCER;

EID: 70349680884     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3181967387     Document Type: Article

References (23)

1. Soofer SB, Sidawy MK. Atypical glandular cells of undetermined significance: clinically significant lesions and means of patient follow-up. Cancer 2000;90:207-214 (Pubitemid 30660107)
2. Kim TJ, Kim HS, Park CT, Park IS, Hong SR, Park JS et al. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. Gynecol Oncol 1999;73:292-298
3. Schnatz PF, Guile M, O'Sullivan DM, Sorosky JL. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol 2006;107:701-708 (Pubitemid 43755628)
4. Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI. Dysplasia associated with atypical glandular cells on cervical cytology [published correction appears in Obstet Gynecol. 2005;105:1495]. Obstet Gynecol 2005;105:494-500.
5. Chhieng DC, Gallaspy S, Yang H, Roberson J, Eltoum I. Women with atypical glandular cells: a long-term follow-up study in a high-risk population. Am J Clin Pathol 2004;122:575-579 (Pubitemid 39281255)
6. Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI. Lack of adherence to practice guidelines for women with atypical glandular cells on cervical cytology [published correction appears in Obstet Gynecol. 2005;105:1495]. Obstet Gynecol 2005;105:501-506
7. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson E, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;197:346-355
8. Chhieng DC, Elgert PA, Cangiarella JF, Cohen JM. Clinical significance of atypical glandular cells of undetermined significance: a follow-up study from an academic medical center. Acta Cytol 2000;44:557-566 (Pubitemid 30640325)
9. DeSimone CP, Day ME, Tovar MM, Dietrich CS, Eastham ML, Modesitt SC. Rate of pathology from atypical glandular cell pap tests classified by the Bethesda 2001 nomenclature. Obstet Gynecol 2006;107:1285-1291
10. Kaferle JE, Malouin JM. Evaluation and management of the AGUS Papanicolaou smear. Am Fam Physician 2001;63:2239-2244 (Pubitemid 32539026)
11. Liu W, Savargaonkar P, Spitzer M, Wasserman P. Atypical glandular cells of undetermined significance: significance of cell type and age on patient management. J Low Genit Tract Dis 2002;6:92-96 (Pubitemid 34575501)
12. Veljovich DS, Stoler MH, Andersen WA. Atypical glandular cells of undetermined significance: a five-year retrospective histopathologic study. Am J Obstet Gynecol 1998;179:382-390 (Pubitemid 28413373)
13. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-428 (Pubitemid 28135669)
14. Surveillance Epidemiology and End Result (SEER); the National Cancer Institute. Fast Stats: SEER incidence for age adjusted cancer rates for cervical cancer, endometrial cancer, breast cancer, and colon cancer in women of all race/ethnicities younger than age 50 between the years 2000 to 2005. Available at: http://seer.cancer.gov/faststats/selections.php?series=cancer. Accessed November 24, 2008.
15. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia - a long term study of "untreated" hyperplasia in 170 patients. Cancer 1985;56:403-412
16. Chhieng DC, Elgert P, Cangiarella JF, Cohen JM. Variation in the incidence of AGUS between different patient populations. Acta Cytol 2001;45:287-293 (Pubitemid 32472779)
17. Chin AB, Bristow RE, Korst LM, Walts A, Lagasse LD. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population. Am J Obstet Gynecol 2000;182:1278-1282 (Pubitemid 30437390)
18. Daniel A, Barreth D, Schepansky A, Johnson G, Capstick V, Faught W. Histologic and clinical significance of atypical glandular cells on Pap smears. Int J Gynaecol Obstet 2005;91:238-242 (Pubitemid 41608769)
19. Doss BJ, Masian AM, Montag AG, Wggoner S, Rotemnsch J, Reeves WA, et al. Atypical glandular cells of undetermined significance in postmenopausal women [abstract]. Mod Pathol 2000;12:33A.
20. Duska LR, Flynn CF, Chen A, Whall-Strojwas D, Goodman A. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet Gynecol 1998;91:278-282 (Pubitemid 28074161)
21. Geier CS, Wilson M, Creasman W. Clinical evaluation of atypical glandular cells of undetermined significance. Am J Obstet Gynecol 2001;184:64-69 (Pubitemid 32141644)
22. Zweizig S, Noller K, Reale F, Collis S, Resseguie L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol 1997;65:314-318 (Pubitemid 27216947)
23. Sahakyam M, Schnatz PF. Menopausal women with AGUS have a higher incidence of glandular lesions [abstract]. Menopause 2003;10(6):605.